Socioeconomic Variations in Use of Prescription Medicines for COPD: A Register-Based Study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Socioeconomic Variations in Use of Prescription Medicines for COPD : A Register-Based Study. / Jacobsen, Ramune; Ekholm, Ola; Rasmussen, Niels K.; Hansen, Ebba Holme; Frølich, Anne.

In: Respiratory Care, Vol. 61, No. 7, 01.07.2016, p. 943-949.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Jacobsen, R, Ekholm, O, Rasmussen, NK, Hansen, EH & Frølich, A 2016, 'Socioeconomic Variations in Use of Prescription Medicines for COPD: A Register-Based Study', Respiratory Care, vol. 61, no. 7, pp. 943-949. https://doi.org/10.4187/respcare.04335

APA

Jacobsen, R., Ekholm, O., Rasmussen, N. K., Hansen, E. H., & Frølich, A. (2016). Socioeconomic Variations in Use of Prescription Medicines for COPD: A Register-Based Study. Respiratory Care, 61(7), 943-949. https://doi.org/10.4187/respcare.04335

Vancouver

Jacobsen R, Ekholm O, Rasmussen NK, Hansen EH, Frølich A. Socioeconomic Variations in Use of Prescription Medicines for COPD: A Register-Based Study. Respiratory Care. 2016 Jul 1;61(7):943-949. https://doi.org/10.4187/respcare.04335

Author

Jacobsen, Ramune ; Ekholm, Ola ; Rasmussen, Niels K. ; Hansen, Ebba Holme ; Frølich, Anne. / Socioeconomic Variations in Use of Prescription Medicines for COPD : A Register-Based Study. In: Respiratory Care. 2016 ; Vol. 61, No. 7. pp. 943-949.

Bibtex

@article{1c9a10f8034c49faba12f092e741867d,
title = "Socioeconomic Variations in Use of Prescription Medicines for COPD: A Register-Based Study",
abstract = "BACKGROUND: The purpose of this study was to examine socioeconomic variations in the use of prescription medicines among elderly subjects with COPD.METHODS: Data from the Danish national administrative registers were used. The study population included 1,365 individuals >60 y old residing in the Municipality of Copenhagen and diagnosed with COPD in a hospital setting in 2007. Logistic regression analysis was applied to examine the associations between the use of all prescription medicines for obstructive pulmonary diseases and the use of long-acting bronchodilators, in subject groups of different socioeconomic position.RESULTS: The study demonstrated that approximately 90{\%} of subjects with COPD purchased at least one prescription medicine for obstructive pulmonary diseases, whereas approximately 50{\%} purchased a long-acting bronchodilator. Medicine use did not vary according to educational status or personal wealth.CONCLUSIONS: There were no systematic socioeconomic differences in the use of relevant prescription medicines in elderly subjects diagnosed with COPD in hospital settings in Copenhagen. However, our findings indicate a gap between guideline recommendations and observed use of long-acting bronchodilators and hence suboptimal quality of treatment in the elderly COPD population.",
author = "Ramune Jacobsen and Ola Ekholm and Rasmussen, {Niels K.} and Hansen, {Ebba Holme} and Anne Fr{\o}lich",
note = "Copyright {\circledC} 2016 by Daedalus Enterprises.",
year = "2016",
month = "7",
day = "1",
doi = "10.4187/respcare.04335",
language = "English",
volume = "61",
pages = "943--949",
journal = "Respiratory Care",
issn = "0020-1324",
publisher = "Daedalus Enterprises, Inc.",
number = "7",

}

RIS

TY - JOUR

T1 - Socioeconomic Variations in Use of Prescription Medicines for COPD

T2 - A Register-Based Study

AU - Jacobsen, Ramune

AU - Ekholm, Ola

AU - Rasmussen, Niels K.

AU - Hansen, Ebba Holme

AU - Frølich, Anne

N1 - Copyright © 2016 by Daedalus Enterprises.

PY - 2016/7/1

Y1 - 2016/7/1

N2 - BACKGROUND: The purpose of this study was to examine socioeconomic variations in the use of prescription medicines among elderly subjects with COPD.METHODS: Data from the Danish national administrative registers were used. The study population included 1,365 individuals >60 y old residing in the Municipality of Copenhagen and diagnosed with COPD in a hospital setting in 2007. Logistic regression analysis was applied to examine the associations between the use of all prescription medicines for obstructive pulmonary diseases and the use of long-acting bronchodilators, in subject groups of different socioeconomic position.RESULTS: The study demonstrated that approximately 90% of subjects with COPD purchased at least one prescription medicine for obstructive pulmonary diseases, whereas approximately 50% purchased a long-acting bronchodilator. Medicine use did not vary according to educational status or personal wealth.CONCLUSIONS: There were no systematic socioeconomic differences in the use of relevant prescription medicines in elderly subjects diagnosed with COPD in hospital settings in Copenhagen. However, our findings indicate a gap between guideline recommendations and observed use of long-acting bronchodilators and hence suboptimal quality of treatment in the elderly COPD population.

AB - BACKGROUND: The purpose of this study was to examine socioeconomic variations in the use of prescription medicines among elderly subjects with COPD.METHODS: Data from the Danish national administrative registers were used. The study population included 1,365 individuals >60 y old residing in the Municipality of Copenhagen and diagnosed with COPD in a hospital setting in 2007. Logistic regression analysis was applied to examine the associations between the use of all prescription medicines for obstructive pulmonary diseases and the use of long-acting bronchodilators, in subject groups of different socioeconomic position.RESULTS: The study demonstrated that approximately 90% of subjects with COPD purchased at least one prescription medicine for obstructive pulmonary diseases, whereas approximately 50% purchased a long-acting bronchodilator. Medicine use did not vary according to educational status or personal wealth.CONCLUSIONS: There were no systematic socioeconomic differences in the use of relevant prescription medicines in elderly subjects diagnosed with COPD in hospital settings in Copenhagen. However, our findings indicate a gap between guideline recommendations and observed use of long-acting bronchodilators and hence suboptimal quality of treatment in the elderly COPD population.

U2 - 10.4187/respcare.04335

DO - 10.4187/respcare.04335

M3 - Journal article

VL - 61

SP - 943

EP - 949

JO - Respiratory Care

JF - Respiratory Care

SN - 0020-1324

IS - 7

ER -

ID: 154367780